Diagnosis and Treatment of Polycystic Ovary Syndrome.
Huddleston HG, Dokras A.
JAMA. 2022 Jan 18;327(3):274-275. doi: 10.1001/jama.2021.23769.
Efficacy and safety of traditional Chinese medicine on treating oligomenorrhea: a systematic review and meta-analysis.
Li Y, Zhao G, Shi W, Zhang Y, Diao H, Ding N, Li P, Zhang F, Yang L, Sun M, Yu H, Li B, Xu L.
Ann Palliat Med. 2021 Dec;10(12):12955-12968. doi: 10.21037/apm-20-825. Epub 2021 Mar 24.
The Prevalence of Menstrual Cycle Disorders in Female Athletes from Different Sports Disciplines: A Rapid Review.
Gimunová M, Paulínyová A, Bernaciková M, Paludo AC.
Int J Environ Res Public Health. 2022 Oct 31;19(21):14243. doi: 10.3390/ijerph192114243.
Herbal Medicine for Oligomenorrhea and Amenorrhea: A Systematic Review of Ancient and Conventional Medicine.
Moini Jazani A, Hamdi K, Tansaz M, Nazemiyeh H, Sadeghi Bazargani H, Fazljou SMB, Nasimi Doost Azgomi R.
Biomed Res Int. 2018 Mar 18;2018:3052768. doi: 10.1155/2018/3052768. eCollection 2018.
The role of oligomenorrhea in melasma.
Mahjour M, Khoushabi A, Feyzabadi Z.
Med Hypotheses. 2017 Jul;104:1-3. doi: 10.1016/j.mehy.2017.05.006. Epub 2017 May 8.
Prevalence of oligomenorrhea among women of childbearing age in China: A large community-based study.
He Y, Zheng D, Shang W, Wang X, Zhao S, Wei Z, Song X, Shi X, Zhu Y, Wang S, Li R, Qiao J.
Womens Health (Lond). 2020 Jan-Dec;16:1745506520928617. doi: 10.1177/1745506520928617.
Myo-inositol vs. D-chiro inositol in PCOS treatment.
Formuso C, Stracquadanio M, Ciotta L.
Minerva Ginecol. 2015 Aug;67(4):321-5. Epub 2015 Feb 11.
Amenorrhea and oligomenorrhea risk related to exercise training volume and intensity: Findings from 3705 participants recruited via the STRAVA exercise application.
Baranauskas MN, Freemas JA, Carter SJ, Blodgett JM, Pedlar CR, Bruinvels G.
J Sci Med Sport. 2023 Aug;26(8):405-409. doi: 10.1016/j.jsams.2023.07.001. Epub 2023 Jul 18.
Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.
Arentz S, Abbott JA, Smith CA, Bensoussan A.
BMC Complement Altern Med. 2014 Dec 18;14:511. doi: 10.1186/1472-6882-14-511.
Discriminating hypothalamic oligomenorrhea/amenorrhea from hyperandrogenic oligomenorrhea/amenorrhea in exercising women.
Koltun KJ, Williams NI, Scheid JL, De Souza MJ.
Appl Physiol Nutr Metab. 2020 Jul;45(7):707-714. doi: 10.1139/apnm-2019-0640. Epub 2019 Dec 9.
